Isabela Rivabem Zanetti (Isabela R Zanetti)

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Liqiang Zhang, Yize Henry Li, Karen V Kibler, Simona Kraberger, Arvind Varsani, Julie Turk, Nora Elmadbouly, Emily Aliskevich, Laurel Spaccarelli, Bereket Estifanos, Junior Enow, Isabela Rivabem Zanetti, Nicholas Saldevar, Efrem Lim, Jessika Schlievert, Kyle Browder, Anjali Wilson, Fernando Arcos Juan, Aubrey Pinteric, Aman Garg, Henna Monder, Rohan Saju, Savanah Gisriel, Bertram Jacobs, Timothy L Karr, Esther Borges Florsheim, Vivek Kumar, John Wallen, Masmudur M Rahman, Grant McFadden, Brenda G Hogue, Alexandra R Lucas
Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection. EMBO molecular medicine (2023)
Isabela Rivabem Zanetti, Michelle Burgin, Liqiang Zhang, Steve T Yeh, Sriram Ambadapadi, Jacquelyn Kilbourne, Jordan R Yaron, Kenneth M Lowe, Juliane Daggett-Vondras, David Fonseca, Ryan Boyd, Dara Wakefield, William Clapp, Efrem S Lim, Hao Chen, Alexandra Lucas
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage. Pathogens (Basel, Switzerland) 11 (5) (2022)

Isabela Rivabem Zanetti.css-eqlu8i{font-size:small;padding-left:4px;} (Isabela R Zanetti)